Chonluten (Glu-Asp-Gly) is a synthetic short-chain peptide bioregulator studied for its regulatory effects on gene expression and tissue homeostasis within bronchial epithelial cells. Available strictly as a research compound for laboratory evaluation, PX1 Research supplies USA-manufactured Chonluten backed by lot-specific mass spectrometry, HPLC purity assays, and endotoxin analysis.
Chonluten (Glu-Asp-Gly) is a synthetic short-chain peptide bioregulator studied for its regulatory effects on gene expression and tissue homeostasis within bronchial epithelial cells. Available strictly as a research compound for laboratory evaluation, PX1 Research supplies USA-manufactured Chonluten backed by lot-specific mass spectrometry, HPLC purity assays, and endotoxin analysis.
Sourcing high-purity bronchial mucosa renewal Chonluten for sale requires strict adherence to analytical verification standards. Chonluten is a synthetic tripeptide consisting of L-glutamic acid, L-aspartic acid, and glycine (Glu-Asp-Gly). In preclinical models, it has demonstrated selective interactions with chromatin structures in bronchial epithelial cells, promoting transcriptomic regulation involved in respiratory tissue repair and mucosal cellular renewal.
PX1 Research provides research-grade Chonluten formulated exclusively for in vitro and laboratory animal research. Every batch is manufactured in USA-based GMP-compliant facilities and undergoes rigorous testing at an ISO 17025 accredited laboratory. Investigators seeking to evaluate peptide-driven transcriptomic alterations, epithelial barrier function, or airway remodeling can access fully transparent third-party Certificates of Analysis (COAs) for every lot.
Chonluten belongs to the class of short peptide bioregulators originally conceptualized to investigate site-specific epigenetic regulation. Structurally identified as L-glutamyl-L-aspartyl-glycine, this tripeptide features a molecular weight of approximately 305.24 g/mol. Due to its short sequence length and charged acidic residues, Chonluten exhibits high solubility in aqueous buffer systems, facilitating clear dosing matrices in cell culture and tissue explant models.
The primary biochemical interest in Chonluten stems from its capacity to pass through cellular and nuclear membranes without requiring complex transport systems. Preclinical research indicates that ultra-short peptides can bind directly to specific histone proteins and DNA promoter regions. This binding interaction alters heterochromatin conformation, thereby modifying transcriptional activity in target genes associated with bronchial epithelial repair and protein synthesis. To explore additional short-chain signaling molecules, visit our comprehensive research peptide library.
In vitro data indicate that Chonluten exerts its regulatory effects primarily through epigenetic modulation rather than classical membrane-receptor agonism. When introduced to cultured human bronchial epithelial cells (HBECs), the tripeptide interacts with the major and minor grooves of double-stranded DNA. This sequence-specific association induces euchromatin formation, uncoiling condensed chromatin segments to allow RNA polymerase access.
Through this structural rearrangement, Chonluten has been observed to reactivate repressed genes associated with cellular differentiation and ribosomal biogenesis. Preclinical studies suggest that this mechanism helps maintain cell viability during oxidative or chemical stress. Researchers investigating epigenetic modifications in respiratory systems frequently utilize Chonluten alongside broader khavinson peptide bioregulators to map gene expression cascades across various cell lines.
A growing body of preclinical literature highlights the role of Chonluten in modulating respiratory tissue homeostasis. In animal models subjected to toxic airway exposures—such as nitrogen dioxide, lipopolysaccharide (LPS), or thermal stress—administration of synthetic Glu-Asp-Gly resulted in accelerated structural recovery of the ciliated epithelial layer. Histological analyses revealed enhanced preservation of microvilli density and reduced desquamation of the mucosal membrane.
Furthermore, organotypic lung slice assays show that Chonluten supports the synthesis of structural proteins, including cytokeratins and mucin-regulating factors. In vitro studies demonstrate that treating damaged bronchial monolayer cultures with Chonluten accelerates transepithelial electrical resistance (TEER) recovery, indicating rapid restoration of tight junction proteins like ZO-1 and occludin. Laboratory teams evaluating airway barrier function can procure high-grade material through our wholesale lab portal for large-scale comparative assays.
In addition to structural renewal, preclinical models demonstrate that Chonluten modulates pro-inflammatory cytokine signaling pathways in pulmonary tissue. In vitro assays using LPS-stimulated alveolar macrophages and bronchial cells indicate that exposure to Glu-Asp-Gly leads to a down-regulation of nuclear factor kappa B (NF-κB) nuclear translocation. Consequently, transcription of inflammatory mediators such as TNF-alpha, IL-1beta, and IL-6 is significantly attenuated.
This dual action—simultaneously suppressing hyper-inflammatory signaling while promoting structural protein synthesis—makes Chonluten a valuable subject for respiratory pathology research. By dampening chronic inflammatory cycles without inducing generalized immunosuppression, the tripeptide helps establish an optimal microenvironment for mucosal tissue regeneration in experimental models.
When evaluating respiratory and tissue repair models, researchers frequently compare Chonluten against other targeted short-chain peptides and mucosal repair agents. While Chonluten (Glu-Asp-Gly) specifically targets bronchial epithelial gene expression, Bronchogen (Ala-Glu-Asp-Pro) represents another short respiratory bioregulator studied for pulmonary tissue remodeling. Similarly, systemic repair compounds like BPC 157 operate via growth factor activation and angiogenic signaling rather than direct chromatin remodeling, offering a complementary mechanism for tissue barrier studies.
Another relevant comparative molecule is Thymogen (Glu-Trp), an immunomodulatory dipeptide often evaluated alongside Chonluten in dual-peptide mucosal immunity protocols. The following matrix illustrates the primary research parameters across these compounds:
To preserve the structural integrity and analytical purity of Chonluten during laboratory experimentation, proper reconstitution procedures must be maintained. Lyophilized Chonluten powder should be brought to room temperature in a desiccator prior to opening to prevent atmospheric moisture condensation. Reconstitution should be performed using sterile, endotoxin-free Bacteriostatic Water or phosphate-buffered saline (PBS, pH 7.4), depending on the requirements of the downstream assay.
Once dissolved, gentle agitation or mild vortexing ensures complete solution homogeneity. For cell culture experiments requiring sterile conditions, the solution may be filtered through a 0.22-micron polyethersulfone (PES) low-protein-binding syringe filter. Aliquoting the reconstituted stock solution into single-use microcentrifuge tubes avoids repeated freeze-thaw cycles, which can cause peptide degradation over extended research timelines.
Lyophilized Chonluten exhibits excellent long-term stability when stored under controlled temperature conditions. For extended storage (up to 24 months), unopened vials must be kept at -20°C or -80°C, protected from direct light exposure. Short-term storage of the dry powder at 2°C to 8°C is acceptable for up to 90 days without measurable degradation.
Reconstituted liquid aliquots should be stored at -20°C and are stable for approximately 3 to 6 months. Refrigerated liquid storage (2°C to 8°C) is recommended for no longer than 7 to 14 days. Researchers must ensure that storage freezers are non-frost-free to eliminate cyclic temperature fluctuations that degrade short-chain peptide bonds.
Procuring research compounds requires rigorous validation of supplier analytical standards. PX1 Research guarantees that every lot of Chonluten is subjected to dual-stage testing prior to distribution. Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) confirms chemical purity exceeding 98.0%, verifying the absence of incomplete peptide sequences or synthesis byproducts.
Electrospray Ionization Mass Spectrometry (ESI-MS) provides exact mass identification to confirm the molecular identity of Glu-Asp-Gly. Furthermore, because bronchial epithelial cell cultures are highly sensitive to bacterial contaminants, PX1 Research subjects all batches to Chromogenic Recombinant Factor C (rFC) endotoxin testing, ensuring endotoxin levels remain strictly below <0.01 EU/mg. Every order includes a downloadable, lot-specific COA for complete laboratory traceability.
PX1 Research is dedicated to supporting the scientific community by supplying premium, USA-manufactured research peptides. We operate under strict quality management protocols within ISO 17025 accredited laboratory frameworks, ensuring that every vial meets exacting scientific specifications. Orders are fulfilled directly from our dispatch centers in California and Arizona, providing rapid same-day shipping (Monday through Friday) to minimize supply chain delays for active experiments.
Whether conducting preliminary in vitro screening or large-scale preclinical studies, PX1 Research delivers full transparency, analytical precision, and dedicated support for institutional buyers. Explore our full catalog of high-purity compounds on our all peptides page to advance your respiratory and cellular biology research.
What primary biological mechanism does Chonluten exhibit in research models?
In preclinical research, Chonluten (Glu-Asp-Gly) acts as an epigenetic bioregulator. It binds to specific DNA promoter regions and histone proteins, promoting euchromatin formation and stimulating transcriptomic expression of genes involved in bronchial epithelial protein synthesis and tissue repair.
What analytical purity level is guaranteed for PX1 Research Chonluten?
PX1 Research guarantees a minimum purity of 98.0% for Chonluten, verified via Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) and mass spectrometry (ESI-MS) by an independent ISO 17025 accredited laboratory.
Is Chonluten approved for human therapeutic use or inhalation therapy?
No. Chonluten supplied by PX1 Research is exclusively formulated as a research compound for in vitro laboratory assays and animal models. It is strictly not for human consumption, clinical use, or medical administration.
What solvents are recommended for reconstituting Chonluten for cell culture assays?
Chonluten is readily soluble in sterile water for injection, Bacteriostatic Water, or standard phosphate-buffered saline (PBS, pH 7.4). For sensitive cell culture protocols, reconstituting in sterile endotoxin-free PBS or culture medium is recommended.
What are the endotoxin limits for PX1 Research Chonluten?
Every lot of Chonluten undergoes strict endotoxin testing and maintains levels below 0.01 EU/mg, preventing endotoxin-induced background inflammation in cell culture and preclinical tissue models.
How should reconstituted Chonluten be stored to maintain long-term stability?
Reconstituted Chonluten should be divided into single-use aliquots and stored at -20°C or -80°C in a non-frost-free freezer. Avoid repeated freeze-thaw cycles to prevent peptide degradation.
How does Chonluten differ structurally from Bronchogen?
Chonluten is a tripeptide composed of L-glutamic acid, L-aspartic acid, and glycine (Glu-Asp-Gly). Bronchogen is a tetrapeptide composed of L-alanine, L-glutamic acid, L-aspartic acid, and L-proline (Ala-Glu-Asp-Pro). Both target pulmonary tissues but exhibit distinct transcriptomic profiles.
Does PX1 Research provide bulk supply options for academic institutions?
Yes. PX1 Research offers institutional pricing and custom bulk synthesis options for high-volume research applications. Lab managers can request accounts through our wholesale research portal.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.